Dr. Dalbagni – who cares for patients with bladder cancer, kidney cancer, penile cancer, and sarcomas – explains treatments offered at Memorial Sloan-Kettering, which can help patients maintain their quality of life.

The Society of MSKCC’s Patient Environment Program funds projects aimed at enriching Memorial Hospital’s physical environment and the comfort of our patients.

Genetic counselor Megan Harlan Fleischut discusses hereditary cancers and the services offered by Memorial Sloan-Kettering’s clinical genetics experts.

Dr. Douer, leader of the research program in acute lymphoblastic leukemia, talks about how patients are treated by a caring team that includes physicians, nurses, social workers, and support staff.

Early research led by investigators at Memorial Sloan-Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.

In his new role as Deputy Physician-in-Chief for Clinical Research, Paul Sabbatini aims to streamline, accelerate, and expand Memorial Sloan-Kettering’s clinical research program.

Dr. Sonoda, who performs minimally invasive procedures when possible, discusses how patients at Memorial Sloan-Kettering have the benefit of an entire team of physicians having input into their care.